USTRx Act Use Sovereignty To reduce Rx Act
A bill to identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.
This bill aims to address international trade practices by high-income countries that unfairly exploit U.S. innovation. It seeks to identify these practices and take action against them, particularly those that deviate from market-based policies. The bill's primary focus is on protecting U.S. innovation from being unfairly exploited by other countries. It was introduced on August 5, 2026, and has been referred to the Committee on Finance for further review.
The bill would primarily affect U.S. innovators and businesses that are currently facing unfair competition from high-income countries. By identifying and tackling these exploitative practices, the bill aims to level the playing field and protect U.S. innovation. This could potentially benefit U.S. companies and innovators by reducing unfair competition from abroad.
As of August 5, 2026, the bill has been introduced and referred to the Committee on Finance. This is the latest status, and the committee will now review the bill, potentially holding hearings and making recommendations for further action.
